Table 3. Regression of central aortic SBP on brachial SBP measured via noninvasive cuff and invasive recordings.
n | β (95% Cl) | P | R2b (95% Cl)c | P | RMSE (95% Cl)c | P | ||
---|---|---|---|---|---|---|---|---|
Device 1 - unadjusted models | ||||||||
Estimated aortic SBP ~ cuff SBP | 171 | 0.89 (0.86; 0.92) | <0.001 | 0.96 (0.95; 0.98) | 3.13(2.80; 3.46) | |||
Invasive aortic SBP ~ brachial SBP | 171 | 0.91 (0.86; 0.97) | <0.001 | 0.85 (0.81; 0.90) | 8.04(7.22; 8.86) | |||
Difference c | 0.11 (0.07; 0.15) | <0.001 | –4.91 (–5.74; –4.08) | <0.001 | ||||
- Adjusted modelsa | ||||||||
Estimated aortic SBP ~ cuff SBP | 164 | 0.89 (0.86; 0.92) | <0.001 | 0.96 (0.95; 0.97) | 3.19(2.86; 3.52) | |||
Invasive aortic SBP ~ brachial SBP | 164 | 0.89 (0.83; 0.94) | <0.001 | 0.88 (0.84; 0.92) | 7.09(6.29; 7.90) | |||
Difference c | 0.08 (0.04; 0.11) | <0.001 | –3.90 (–4.70; –3.10) | <0.001 | ||||
Device 2 - unadjusted models | ||||||||
Estimated aortic SBP ~ cuff SBP | 52 | 1.03 (0.96; 1.09) | <0.001 | 0.95 (0.92; 0.98) | 4.01 (3.28; 4.75) | |||
Invasive aortic SBP ~ brachial SBP | 52 | 0.95 (0.86; 1.05) | <0.001 | 0.89 (0.85; 0.94) | 6.74 (5.80; 7.69) | |||
Difference c | 0.06 (0.02; 0.09) | ≤0.001 | –2.73 (–3.81;–1.65) | <0.001 | ||||
- Adjusted modelsa | ||||||||
Estimated aortic SBP I cuff SBP | 40 | 1.05 (0.98; 1.12) | <0.001 | 0.97 (0.95; 0.99) | 3.63(2.79; 4.46) | |||
Invasive aortic SBP I brachial SBP | 40 | 0.95 (0.84; 1.07) | <0.001 | 0.89 (0.84; 0.95) | 7.16(5.74; 8.58) | |||
Difference c | 0.08 (0.03; 0.13) | 0.002 | –3.53 (–5.02; –2.04) | <0.001 |
Sphygmocor Xcel and Uscom BP+ were defined as device 1 and device 2. respectively. Data are unstandardized beta (95% confident interval).
Models are adjusted for age. sex, height, and invasive aortic heart rate.
Adjusted R2.
Adjusted R2 (95% Cl) and RMSE (95% Cl) differences between noninvasive and invasive models calculated by bootstrapping with 2000 replications Cl. confidence interval, RMSE. root mean square error: SBP systolic blood pressure.